Company / Depreciation & Amortization
BioLife Solutions, Inc. Depreciation & Amortization History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.3M
FY2025
5-year range
$2.3M / $7.1M
FY2021-FY2025
Trend
-56.3%
vs FY2024
Sector context
#130 of 135
Health Care
What the data says
Among 135 Health Care companies, BioLife Solutions, Inc. is in the top 4% for depreciation & amortization. Improved from $7M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +2.1%.
Improved from $7M to $2M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -30.7%
- 5-Year CAGR
- +2.1%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 135This company $2.3M Sector average $334.5M
▼
-99.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.1%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 56.3% year-over-year.
- Ranks #130 out of 135 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.3M | -56.3% |
| FY2024 | $5.2M | -27.5% |
| FY2023 | $7.1M | +5.0% |
| FY2022 | $6.8M | +45.3% |
| FY2021 | $4.7M | +129.1% |
| FY2020 | $2.0M | +183.4% |
| FY2019 | $718.0K | +820.5% |
| FY2018 | $78.0K | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026